FGF21 and glucose measurement: GCGR mAb significantly lowered fasting blood glucose level and improved glucose tolerance in WT and Fgf21−/− mice (Fig. 4b,c), indicating that FGF21 was not a key mediator in the GCGR mAb-induced hypoglycaemic effect.